
Number of publications published per year by Bronk, Steven F.. (Source : PubMed)

Distribution of publications types for Bronk, Steven F.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Palmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosis.
J. Hepatol.
2010;52;4

A Bax-mediated mechanism for obatoclax-induced apoptosis of cholangiocarcinoma cells.
Cancer Res.
2010;70;5

Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2.
Hepatology
2009;50;6

Overexpression of mcl-1 attenuates liver injury and fibrosis in the bile duct-ligated mouse.
Dig. Dis. Sci.
2009;54;9
Matrix metalloproteinase inhibitor, CTS-1027, attenuates liver injury and fibrosis in the bile duct-ligated mouse.
Hepatol. Res.
2009;39;8


Death receptor 5 internalization is required for lysosomal permeabilization by TRAIL in malignant liver cell lines.
Gastroenterology
2009;136;7

Nitric oxide promotes caspase-independent hepatic stellate cell apoptosis through the generation of reactive oxygen species.
Hepatology
2008;47;6

TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouse.
Hepatology
2008;47;4

Constitutive androstane receptor agonist, TCPOBOP, attenuates steatohepatitis in the methionine choline-deficient diet-fed mouse.
World J. Gastroenterol.
2007;13;42

mir-29 regulates Mcl-1 protein expression and apoptosis.
Oncogene
2007;26;42
[ See timeline ] [ See all publications ]
means that Bronk, Steven F. has 35 papers cited a least 35 times - methodology
Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.